Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
Contribution of Myelin Content to the PET-Measured Amyloid Burden.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhou Liangdong, Keil Samantha, Wang Xiuyuan H, Hojjati Seyed Hani, Castellanos Carmen Barrios, Wartchow Krista M, Dartora William J, Mclntire Laura Beth, Chiang Gloria C, Li Yi, Butler Tracy A
Аннотация
Off-target binding to white matter myelin is well established in amyloid-β (Aβ) PET. Whether tracer binding to intracortical myelin influences cortical PET quantification remains unknown. We tested whether accounting for myelin water fraction (MWF), an MRI measure of myelin, improves the correlation between Aβ PET and the Alzheimer disease (AD) plasma biomarker phosphorylated tau 217 (p-tau217). Methods: This study included 114 participants with and without AD who underwent Aβ PET with 11C-Pittsburgh compound B (n = 60) or 18F-florbetaben (n = 54), multiecho fast T2 MRI to quantify MWF, and semiquantitative in vitro diagnostic immunoassay to measure plasma p-tau217 levels. Cortical Aβ burden was quantified using SUV ratio and Centiloids. Nested regression models predicted PET signal using age and p-tau217 level, with and without cortical MWF. Results: MWF independently predicted PET-measured Aβ signal and improved model fit by approximately 6% in both the combined and tracer-specific cohorts. Conclusion: Intracortical myelin contributes to Aβ PET signal. Incorporating MWF may improve Aβ PET quantification, with implications for AD diagnosis, patient selection, and monitoring response to anti-Aβ therapies.